These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24635556)

  • 1. Dendrimers for gene delivery--a potential approach for ocular therapy?
    Chaplot SP; Rupenthal ID
    J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.
    Rodríguez Villanueva J; Navarro MG; Rodríguez Villanueva L
    Int J Pharm; 2016 Sep; 511(1):359-366. PubMed ID: 27436708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer nanoparticles for ocular drug delivery.
    Kambhampati SP; Kannan RM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
    Kalomiraki M; Thermos K; Chaniotakis NA
    Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advance of dendrimers--a versatile targeting platform for gene/drug delivery.
    Parekh HS
    Curr Pharm Des; 2007; 13(27):2837-50. PubMed ID: 17897027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ocular disorders by gene therapy.
    Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(amidoamine) dendrimer complexes as a platform for gene delivery.
    Shcharbin D; Shakhbazau A; Bryszewska M
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1687-98. PubMed ID: 24168461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
    O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology in ocular delivery: current and future directions.
    Sultana Y; Maurya DP; Iqbal Z; Aqil M
    Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.
    Tarach P; Janaszewska A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to ocular drug delivery.
    Davis JL; Gilger BC; Robinson MR
    Curr Opin Mol Ther; 2004 Apr; 6(2):195-205. PubMed ID: 15195932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors.
    Luo K; He B; Wu Y; Shen Y; Gu Z
    Biotechnol Adv; 2014; 32(4):818-30. PubMed ID: 24389086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers in gene delivery.
    Dufès C; Uchegbu IF; Schätzlein AG
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2177-202. PubMed ID: 16310284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.